Furthermore, it is demonstrated that PSMA5 silencing inhibits proliferation, migration, and invasion and induces apoptosis of prostate cancer and LUAD cells, while increasing the sensitivity of the cells to bortezomib or cisplatin,24, 25 suggesting that PSMA5 acts as an oncogenic protein in these two types of cancers. The gene discussed is PSMA5; the disease is prostate cancer.